Amy Qin
Impact in
- Oncology top 5%
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
-
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 4
- Vascular Tumors and Angiosarcomas 3
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 1
-
- Lung Cancer Treatments and Mutations 4
- Sarcoma Diagnosis and Treatment 3
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Jan Cosaert (4 shared papers)Robert Ilaria (4 shared papers)Ashwin Shahir (4 shared papers)Robin L. Jones (2 shared papers)Matthew M. Cooney (2 shared papers)Damien M. Cronier (2 shared papers)Bartosz Chmielowski (2 shared papers)Michael B. Livingston (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of the National Comprehensive Cancer Network (1 paper)Lung Cancer (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Amy Qin
11 papers receiving 709 citations
Amy Qin's Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 472
- Pulmonary and Respiratory Medicine 487
- Gastroenterology 50
- Cardiology and Cardiovascular Medicine 130
- Pathology and Forensic Medicine 99
Countries citing papers authored by Amy Qin
This map shows the geographic impact of Amy Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Qin more than expected).
Fields of papers citing papers by Amy Qin
This network shows the impact of papers produced by Amy Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Qin. The network helps show where Amy Qin may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Qin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial Hit paper breakdown → | 2016 | 436 |
| 2 | Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study Hit paper breakdown → | 2023 | 124 |
| 3 | 2016 | 56 | |
| 4 | 2014 | 50 | |
| 5 | 2015 | 14 | |
| 6 | 2021 | 11 | |
| 7 | 2018 | 10 | |
| 8 | 2017 | 9 | |
| 9 | 2020 | 7 | |
| 10 | 2015 | 2 | |
| 11 | 2014 | 1 | |
| 12 | 2025 | 0 |
About Amy Qin
Amy Qin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Hematology and Gastroenterology, having authored 12 papers that have together received 720 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), HER2/EGFR in Cancer Research (4 papers), Vascular Tumors and Angiosarcomas (3 papers), Sarcoma Diagnosis and Treatment (3 papers), Gastric Cancer Management and Outcomes (3 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (472 citations), Pulmonary and Respiratory Medicine (487 citations), Gastroenterology (50 citations), Cardiology and Cardiovascular Medicine (130 citations) and Pathology and Forensic Medicine (99 citations). Amy Qin has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Jan Cosaert, Robert Ilaria, Ashwin Shahir, Robin L. Jones, Matthew M. Cooney, Damien M. Cronier, Bartosz Chmielowski, Michael B. Livingston, William D. Tap and Ilaria Conti. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Journal of the National Comprehensive Cancer Network, Lung Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.